- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01762241
Xbox Kinect Training in Men With Prostate Cancer
Xbox Kinect Training in Men With Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy
The purpose of this study is to investigate the effect of 12 weeks systematically training using the Xbox Kinect system.
Outcome measures are made on physical function, quality of life, fatigue and metabolic parameters.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients will be recruited from the outpatient clinic at the urological department, Regionshospitalet Holstebro.
Patients who have been discharged from the outpatient clinic due to biochemical stabile cancer prostate disease will receive a letter with information about the study.
A research assistant will be responsible for randomization and test procedures. A physiotherapist will be responsible for instruction of the participants to the training and the Xbox system.
A student will be responsible for installation and collection of the Xbox system in the participants home.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aarhus, Denmark, 8000
- Urinvejskirurgisk afdeling, Aarhus Universitetshospital, Skejby
-
Holstebro, Denmark, 7500
- Regionshospitalet Holstebro, Urinvejskirurgisk afdeling
-
Viborg, Denmark, 8800
- Urologisk afdeling, Regionshospitalet Viborg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Prostate cancer requiring androgen deprivation therapy
- Androgen deprivation therapy for at least 3 month prior to inclusion
- Cognitive well-functioning in order to be able to answer questionnaires and train according to instructions
- Signed informed consent
Exclusion Criteria:
- Prostate cancer with metastasis to other regions than bones
- Strength- or cardiovascular training 2 times or more per week prior to inclusion
- Haemoglobin percentage less than 6,1 mmol/l
- Any mental or physical condition that makes the patient unfit for participation
- Men in risk of getting an osteoporotic fracture due to long-term treatment with steroids or earlier fractures due to minimal trauma
- Participation in other studies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
12 weeks systematically home based training 3 times per week one hour at the time using the Xbox Kinect system.
|
Home based training 3 times a week for 12 weeks using the Xbox Kinect system
|
No Intervention: Control group
No systematically training/standard of care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The effect of 12 weeks systematically training with the Xbox Kinect system on physical function
Time Frame: Change from baseline to week 12
|
6 min walk test
|
Change from baseline to week 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The effect of 12 weeks systematically training with the Xbox Kinect on body composition
Time Frame: Change from baseline to week 12
|
Method: BIoelectrical impedance analysis Bioelectrical impedance
|
Change from baseline to week 12
|
The effect of 12 weeks systematically training with the Xbox Kinect system on physical function
Time Frame: Change from baseline to week 12
|
Leg extensor power
|
Change from baseline to week 12
|
The effect of 12 weeks systematically training with the Xbox Kinect system on fatigue
Time Frame: Change from baseline to week 12
|
Fatigue measured using the Functional Assessment of Canter Therapy-Fatigue questionnaire
|
Change from baseline to week 12
|
The effect of 12 weeks systematically training with the Xbox Kinect system on quality of life
Time Frame: Change from baseline to week 12
|
Quality of life measured using the Functional Assessment of Canter Therapy-Prostate questionnaire
|
Change from baseline to week 12
|
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12
|
Waist circumference (cm)
|
Change from baseline to week 12
|
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12
|
Blood pressure (mmHg)
|
Change from baseline to week 12
|
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12
|
Body weight (kg)
|
Change from baseline to week 12
|
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
|
Blood glucose (mmol/L)
|
Change from baseline to week 12 and week 24
|
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
|
Plasma triglyceride (mmol/L)
|
Change from baseline to week 12 and week 24
|
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
|
Plasma cholesterol (mmol/L)
|
Change from baseline to week 12 and week 24
|
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
|
Plasma High-density lipoprotein (HDL-cholesterol) (mmol/L)
|
Change from baseline to week 12 and week 24
|
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
|
Plasma Low-density lipoprotein (LDL-cholesterol) (mmol/L)
|
Change from baseline to week 12 and week 24
|
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
|
Leptin (µg/L)
|
Change from baseline to week 12 and week 24
|
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
|
Adiponectin (mg/L)
|
Change from baseline to week 12 and week 24
|
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
|
Leptin:Adiponectin ratio
|
Change from baseline to week 12 and week 24
|
The effect of 12 weeks systematically training with the Xbox Kinect system on the prevalence of the metabolic syndrome
Time Frame: Change from baseline to week 12
|
The five components of the metabolic syndrome: blood glucose, triglyceride, HDL-cholesterol, waist circumference, blood pressure
|
Change from baseline to week 12
|
The effect of 12 weeks systematically training with the Xbox Kinect system on insulin
Time Frame: Change from baseline to week 12 and week 24
|
Insulin (pmol/L)
|
Change from baseline to week 12 and week 24
|
The effect of 12 weeks systematically training with the Xbox Kinect system on insulin resistance
Time Frame: Change from baseline to week 12 and week 24
|
Homeostasis model assessment for insulin resistance (HOMA-IR)
|
Change from baseline to week 12 and week 24
|
The effect of 12 weeks systematically training with the Xbox Kinect system on Insulin Growth Factor-I (IGF-I), bioactive IGF, and IGF-II
Time Frame: Change from baseline to week 12 and week 24
|
IGF-I, bioactive IGF and IGF-II (µg/L)
|
Change from baseline to week 12 and week 24
|
The effect of 12 weeks systematically training with the Xbox Kinect system on Insulin Growth Factor Binding Protein 1-3 (IGFBP 1-3)
Time Frame: Change from baseline to week 12 and week 24
|
IGFBP 1-3 (µg/L)
|
Change from baseline to week 12 and week 24
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Brigitta R Villumsen, M.S.N., Hospitalsenheden Vest
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Wii-1-10-72-593-12
- 1-10-72-593-12 (Other Identifier: Hospitalsenheden Vest)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Cancer
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ryan Kohlbrenner, MDRadiological Society of North AmericaCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage...United States
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.TerminatedRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate...United States
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate...United States
Clinical Trials on Home based training using the Xbox Kinect system
-
Klinik ValensState Secretariat for Education Research and Innovation, Switzerland; Office...CompletedGeriatric Disorder | Mobility LimitationsSwitzerland
-
Mahidol UniversityWarakorn Charoensuk; Apiphan Iamchaimongkol; Tulyapruek TawonsawatrukWithdrawnUpper Extremity Problem | Cerebral Palsy Children
-
Mahidol UniversityWarakorn Charoensuk; Apiphan Iamchaimongkol; Tulyapruek TawonsawatrukCompleted
-
Mahidol UniversityWarakorn Charoensuk; Apiphan Iamchaimongkol; Tulyapruek TawonsawatrukRecruitingUpper Extremity Problem | Cerebral Palsy ChildrenThailand
-
Aristotle University Of ThessalonikiCompletedCardiovascular DiseasesGreece
-
Grand Valley State UniversityNot yet recruitingCerebral PalsyUnited States
-
Tel-Aviv Sourasky Medical CenterHIT Holon Institute of TechnologyUnknown
-
Chang Gung Memorial HospitalRecruitingStroke | Cerebrovascular Disorders | Central Nervous System DiseasesTaiwan
-
CochlearAvania; QbD ClinicalRecruiting
-
Universitaire Ziekenhuizen KU LeuvenUniversity of BaselUnknown